HomeCompareIMIAY vs MRK

IMIAY vs MRK: Dividend Comparison 2026

IMIAY yields 27.75% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $28.5K in total portfolio value· pulled ahead in Year 6
10 years
IMIAY
IMIAY
● Live price
27.75%
Share price
$35.20
Annual div
$9.77
5Y div CAGR
-38.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.2K
Annual income
$32.86
Full IMIAY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — IMIAY vs MRK

📍 MRK pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIMIAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IMIAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
IMIAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IMIAY
Annual income on $10K today (after 15% tax)
$2,358.78/yr
After 10yr DRIP, annual income (after tax)
$27.93/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,300.48/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IMIAY + MRK for your $10,000?

IMIAY: 50%MRK: 50%
100% MRK50/50100% IMIAY
Portfolio after 10yr
$42.5K
Annual income
$4,915.50/yr
Blended yield
11.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

IMIAY
Analyst Ratings
4
Buy
2
Hold
Consensus: Buy
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IMIAY buys
0
MRK buys
0
No recent congressional trades found for IMIAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIMIAYMRK
Forward yield27.75%2.76%
Annual dividend / share$9.77$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-38.1%32.7%
Portfolio after 10y$28.2K$56.8K
Annual income after 10y$32.86$9,798.13
Total dividends collected$5.2K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: IMIAY vs MRK ($10,000, DRIP)

YearIMIAY PortfolioIMIAY Income/yrMRK PortfolioMRK Income/yrGap
1$12,418$1,717.75$11,206$366.19+$1.2KIMIAY
2$14,521$1,233.98$12,650$502.35+$1.9KIMIAY
3$16,372$834.77$14,407$694.19+$2.0KIMIAY
4$18,063$544.49$16,585$967.82+$1.5KIMIAY
5$19,675$347.51$19,342$1,363.89+$333.00IMIAY
6← crossover$21,271$218.98$22,913$1,947.19$1.6KMRK
7$22,897$136.96$27,662$2,823.89$4.8KMRK
8$24,585$85.29$34,159$4,173.35$9.6KMRK
9$26,359$52.98$43,337$6,308.80$17.0KMRK
10$28,237$32.86$56,776$9,798.13$28.5KMRK

IMIAY vs MRK: Complete Analysis 2026

IMIAYStock

IMI plc, a specialist engineering company, designs, manufactures, and services engineered products worldwide. The company operates through three divisions: IMI Precision Engineering, IMI Critical Engineering, and IMI Hydronic Engineering. The IMI Precision Engineering division develops motion and fluid control technologies for industrial automation, commercial vehicle, life sciences, energy, and rail applications. This division offers actuators, air preparation products, pressure switches, and fittings; pneumatic, hydraulic, electric, and vacuum motion solutions; solenoid valves, angle-seat valves, motorized valves, and systems for dust filters; miniature fluid control solutions; precise and accurate syringes, syringe pumps, and rotary valves; cab chassis, powertrain solutions, stainless steel valves and regulators, and emergency shutdown controls; and stainless steel valves and regulators, nuclear class valves, and emergency shutdown controls. It provides its products under the Norgren, Bimba, Buschjost, FAS, Herion, Kloehn, Adaptas, and Maxseal brands. The IMI Critical Engineering division offers specialized valves and actuators to the fossil power, oil and gas, petrochemical, nuclear, marine, and pharmaceutical markets under the IMI Bopp & Reuther, IMI CCI, IMI Fluid Kinetics, IMI NH, IMI Orton, IMI Remosa, IMI STI, IMI TH Jansen, IMI Thompson Valves, IMI Truflo Marine, IMI Truflo Rona, IMI PBM, and IMI Z&J brands. The IMI Hydronic Engineering division provides products for hydronic distribution systems, which deliver heating and cooling systems to the residential and commercial building sectors. This segment offers balancing and control solutions, thermostatic control systems, and pressure maintenance systems, dirt and air separators, and pressure step degassers under the IMI Pneumatex, IMI TA, IMI Flow Design, IMI Heimeier, and IMI Aero-Dynamiek brands. The company was founded in 1862 and is headquartered in Birmingham, the United Kingdom.

Full IMIAY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this IMIAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IMIAY vs SCHDIMIAY vs JEPIIMIAY vs OIMIAY vs KOIMIAY vs MAINIMIAY vs JNJIMIAY vs ABBVIMIAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.